ACHIEVE LIFESCI Stock Price (NASDAQ:ACHV)

Add to My Stocks
$2.59 $0.01 (0.38%) ACHV stock closing price Sep 18, 2018 (Closing)
Prev Close* : $2.6
Market Cap:
$11.83M
Day Low: $2.4
52 Week Low: $2.40
Open: $2.81
Volume: -
Day High: $2.81
52 Week High: $38.45
Dividend:
0.00

Latest Stock Market News

Latest Articles

ACHIEVE LIFESCI News - From Partners

ACHV Stockcharts

View ACHV PE ratio, PS ratio stocks charts and compare with peers.
ACHV Chart
Note: Compare ACHIEVE LIFESCI stock price history with the index and industry peers.

ACHIEVE LIFESCI Valuation

PE ratio
(price earnings ratio)
-999.0000
PS ratio (
price to sales ratio
)
-999.0000
PB ratio (
price to book ratio
)
-999.0000

ACHIEVE LIFESCI Returns

ROE
(return on equity)
-148%

ACHIEVE LIFESCI Financial Ratios

Asset Turnover
0
Receivables Turnover
0
Debt to Equity
0
Dividend Yield
-999.0000

ACHV Industry Peers

Company Price Change (%)
Precision Therp (AIPT)1.050.04 (3.96%)
Bio-path (BPTH)1.080.05 (4.42%)
Relmada Therapeutics (RLMD)0.950 (0%)
Ohr Pharmaceuticals (OHRP)0.190 (0%)
Redhill Biopharma (RDHL)80.14 (1.78%)
Immunomedics (IMMU)22.390.15 (0.67%)
Aduro Biotech (ADRO)6.750.55 (8.87%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
ChemoCentryx (CCXI)11.521.03 (9.82%)
AcelRx Pharma (ACRX)3.750.3 (8.7%)
MELINTA THERAPT (MLNT)4.450.35 (8.54%)
Galectin Therapeutics (GALT)6.020.28 (4.88%)
GlycoMimetics (GLYC)14.580.67 (4.82%)
Achaogen (AKAO)4.280.17 (4.14%)
Concert Pharma (CNCE)13.420.51 (3.95%)
Top gainers from Medical-Drugs industry
* As of Sep 18, 2018
CompanyPriceChange (%)
MADRIGAL PHARMA (MDGL)207.321.13 (9.25%)
Tetraphase Pharmaceuticals (TTPH)2.90.16 (5.23%)
Recro Pharma (REPH)7.410.29 (3.77%)
Corcept Therapeutics (CORT)14.260.48 (3.26%)
Lannett Co (LCI)4.750.15 (3.06%)
Catalyst Pharma (CPRX)3.10.09 (2.82%)
Galmed Pharma (GLMD)12.610.24 (1.87%)
Top losers from Medical-Drugs industry
* As of Sep 18, 2018

ACHIEVE LIFESCI Stock News - Partner Headlines

ACHIEVE LIFESCI Financial Statements

income statement20172016201520142013
Net Sales or Revenues-5.06M18.16M27.11M29.88M
Net Income-10.58M-20.12M-16.8M-26.24M-31.84M
Total Operating Expense6.63M26.24M36.9M56.57M65.2M
View ACHIEVE LIFESCI income statement
balance sheet20172016201520142013
Total Assets9.89M27.47M58.2M56.29M55.68M
Total Liabilities2.01M8.5M20.76M22.23M18.47M
Shareholders Equity7.87M18.96M37.44M34.05M37.21M
View ACHIEVE LIFESCI balance sheet
cash flow statement20172016201520142013
Net Increase (Decrease) in Assets Liabilities-3.09M-10.72M7.02M11.57M-3.93M
Net Cash from (used by) Operating Activities-9.1M-29.68M-9.1M-17.3M-35.92M
Increase (Decrease) in Prop Plant And Equipment--0.04M-0.37M-0.08M-0.25M
View ACHIEVE LIFESCI cash flow statement

ACHIEVE LIFESCI Stock Message Board

ACHIEVE LIFESCI stock lost 0.38%, and the last close price as of Sep 18, 2018 is $2.59 for ACHV stock. Looking at ACHIEVE LIFESCI market capitalization, which currently stands at $11.83M, we can say that ACHV stock is a Nano Cap stock. Investors can use valuation multiples like the P/E ratio, price to sales ratio etc. for performing ACHIEVE LIFESCI stock analysis.

For recognizing and analyzing the real performance of ACHIEVE LIFESCI stock, it is a standard practise to adjust historical stock prices to remove gaps caused by stock splits, dividends and distributions. The volume number in ACHIEVE LIFESCI stock quote data shows the number of shares traded. For Ex: 82,131 ACHIEVE LIFESCI shares were traded as of last trading day, as seen from ACHIEVE LIFESCI stock chart. The board of directors decide what percentage of a company's earnings will be paid out as dividends. ACHIEVE LIFESCI stock dividend was 0.00 during the last quarter. ACHIEVE LIFESCI stock price history has details about historical stock quotes, P/E ratios and price to sales ratios.